viracta.com - Bathi operasional EBITDA VIRX
Viracta Therapeutics management is focused on creating innovative methods to combat viral tumors. The actual size of operating profit demonstrates current business efficiency, where serves as the current parameter value. The company minimizes its environmental footprint during drug development, while exclusive patent rights for lymphoma therapy provide it with a significant competitive advantage.
Viracta Therapeutics, Inc. (VIRX) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Utang marang Ekuitas Viracta Therapeutics|VIRX - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Viracta Therapeutics Inc.|VIRX - Utang perusahaan|Rasio utang marang aset resik Viracta Therapeutics|VIRX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Viracta Therapeutics|Indikator likuiditas cepet viracta.com
- statistik bathi lan rasio pasar:
VIRX - Penghasilan resik|Bathi resik mangsa ngarep Viracta Therapeutics|VIRX - Pangali P/E|Pangali Forward P/E Viracta Therapeutics Inc.|VIRX - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Viracta Therapeutics|VIRX - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Viracta Therapeutics|VIRX - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan viracta.com|VIRX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Viracta Therapeutics
Analisis kabeh metrik perusahaan:Viracta Therapeutics
This indicator measures net cash flow from operating activities before depreciation and amortization, allowing for an assessment of the business's actual ability to generate profit regardless of debt load. An analysis of the EBITDA value for Viracta Therapeutics (VIRX) confirms the effectiveness of ESG standard integration and the minimization of bio-waste in biopharmaceuticals, protecting the investor from overpaying for overvalued assets through precise tracking of operating return expansion rates.
Karo sapa Viracta Therapeutics saingan
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Bicara Corp BCAX|Bathi operasional sadurunge ngurangi amortisasi PSNL (Personalis, Inc.)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ERAS (erasca.com)|Bathi operasional EBITDA DCTH (Delcath Systems)|Pendapatan operasional sadurunge ngurangi amortisasi Y-mAbs Therapeutics Inc (YMAB)|AURA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CADL (Candel Therapeutics)|ARAY: Bathi operasional EBITDA|SELLAS Life Sciences Group (SLS) - Bathi operasional EBITDA|ACTU (Actuate Therapeutics) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Citius Oncology Inc. (CTOR)|Bathi operasional sadurunge ngurangi amortisasi HURA (TuHURA Biosciences, Inc.)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi TARA|Bathi operasional EBITDA FATE (Fate Therapeutics, Inc.)|Bathi operasional EBITDA Aadi Bioscience, Inc. WHWK|TCRX: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi CSBR (Champions Oncology)|XBIT (xbiotech.com) - Bathi operasional sadurunge ngurangi amortisasi|CVM: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|OSTX (OS Therapies Incorporated) - Bathi operasional EBITDA|RADX: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ARTV|ANL - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Veru Pharma VERU|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TPST|Xilio - Bathi operasional EBITDA|RENB - Bathi operasional EBITDA|muraloncology.com (MURA) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi KAPA (Kairos Pharma)|OKUR (OnKure Therapeutics, Inc.) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi CytoMed GDTC|Bathi operasional sadurunge ngurangi amortisasi CRIS (Curis, Inc.)|Bathi operasional EBITDA apollomicsinc.com (APLM)|Tharimmune - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi ADVB (Advanced Biomed Inc.)|Genprex, Inc - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Calidi Biotherapeutics CLDI|SBFM: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Xenetic Biosciences, Inc.|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Salarius Pharmaceuticals, Inc.|Purple Biotech Ltd (PPBT) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi AONC (American Oncology Network)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi BGNE (BeiGene Ltd)|Bathi operasional EBITDA CKPT (Checkpoint Therapeutics)|Pendapatan operasional sadurunge ngurangi amortisasi elevationoncology.com (ELEV)|ICAD - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi IKNA (Ikena Oncology, Inc.)|NTBL (Notable Labs Inc.) - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge amortisasi MOR|NAYA (NAYA Biosciences) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi ascentage.com (AAPGV)
